Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome

Autor: Carmino De Souza, Vigorito, A. C., Ruiz, M. A., Nucci, M., Dulley, F. L., Funcke, V., Tabak, D., Azevedo, A. M., Byington, R., Macedo, M. C., Saboya, R., Aranha, F. J. P., Oliveira, G. B., Zulli, R., Miranda, E. C. M., Azevedo, W. M., Lodi, F. M., Voltarelli, J. C., Simões, B. P., Colturato, V., Souza, M. P., Silla, L., Bittencourt, H., Piron-Ruiz, L., Maiolino, A., Gratwohl, A., Pasquini, R.

Publikováno v: Europe PubMed Central
Scopus-Elsevier

The management of chronic myeloid leukemia (CML) has changed radically since the introduction of imatinib therapy. The decision of whether to offer a patient a hematopoietic stem cell transplant (HSCT) must be based on the probability of success of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9e4177a8edfbf35163ddf937d7b5905e
https://pubmed.ncbi.nlm.nih.gov/15713580

Evidence of neutral radical induced analyte ion transformations in APPI and near-VUV APLI.

Autor: Kersten H; Department of Physical and Theoretical Chemistry, University of Wuppertal, Wuppertal, Germany. hkersten@uni-wuppertal.de, Funcke V, Lorenz M, Brockmann KJ, Benter T, O'Brien R

Publikováno v: Journal of the American Society for Mass Spectrometry [J Am Soc Mass Spectrom] 2009 Oct; Vol. 20 (10), pp. 1868-80. Date of Electronic Publication: 2009 Jul 03.

Thermogenic Adipocytes Promote M2 Macrophage Polarization through CNNM4-Mediated Mg Secretion.

Autor: Zhang A; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China.; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, P. R. China.; Clinical Research Center for Neurological Diseases of Zhejiang Province, Hangzhou, 310009, P. R. China., Jiang J; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China., Zhang C; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China., Xu H; Department of Neurosurgery, Huashan Hospital Affiliated to Fudan University, School of Medicine, Fudan University, Shanghai, 200040, P. R. China., Yu W; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China., Zhang ZN; Translational Medical Center for Stem Cell Therapy and Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200120, China., Yuan L; School of Public Health, School of Medicine, Shanghai Jiaotong University, Shanghai, 200025, China., Lu Z; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China., Deng Y; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China., Fan H; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China.; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, P. R. China., Fang C; Department of Neurosurgery, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200080, P. R. China., Wang X; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China.; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, P. R. China., Shao A; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China.; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, P. R. China., Chen S; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China.; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, P. R. China., Li H; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China.; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, P. R. China., Ni J; College of Biological Science and Medical Engineering, Donghua University, 2999 North Renmin Road, Shanghai, 201620, China., Wang W; College of Biological Science and Medical Engineering, Donghua University, 2999 North Renmin Road, Shanghai, 201620, China., Zhang X; State Key Laboratory of Metal Matrix Composites, School of Materials Science and Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.; Suzhou Origin Medical Technology Co. Ltd., Suzhou, 215513, China., Zhang J; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, P. R. China.; Clinical Research Center for Neurological Diseases of Zhejiang Province, Hangzhou, 310009, P. R. China.; Brain Research Institute, Zhejiang University, Hangzhou, 310009, P. R. China.; MOE Frontier Science Center for Brain Science and Brain-Machine Integration, Zhejiang University, Hangzhou, 310009, P. R. China., Luan B; Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, 200065, P. R. China.

Publikováno v: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Nov 08, pp. e2401140. Date of Electronic Publication: 2024 Nov 08.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission.

Autor: Versluis, J¹, Labopin, M², Niederwieser, D³, Socie, G⁴, Schlenk, R F⁵, Milpied, N⁶, Nagler, A⁷, Blaise, D⁸, Rocha, V⁹, Cornelissen, J J¹, Mohty, M²

Publikováno v: Leukemia (08876924). Jan2015, Vol. 29 Issue 1, p51-57. 7p.